173 related articles for article (PubMed ID: 9557928)
21. [Effects of benidipine hydrochloride (Coniel) on blood pressure, heart rate and plasma norepinephrine concentration in spontaneously hypertensive rats].
Karasawa A; Nomura H; Nito M; Sonoda R; Tanaka H; Kosaka N; Yamaguchi K; Kobayashi S
Nihon Yakurigaku Zasshi; 1999 May; 113(5):317-26. PubMed ID: 10480159
[TBL] [Abstract][Full Text] [Related]
22. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
Huang W; Alhenc Gelas F; Osborne-Pellegrin MJ
Circ Res; 1998 May; 82(8):879-90. PubMed ID: 9576107
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of mibefradil and other calcium antagonists on resistance arteries of different end organs.
van der Lee R; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 1999; 13(2):198-203. PubMed ID: 10226764
[TBL] [Abstract][Full Text] [Related]
24. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine].
Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M
Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425
[TBL] [Abstract][Full Text] [Related]
25. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
Brogden RN; Markham A
Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
[TBL] [Abstract][Full Text] [Related]
26. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.
Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
J Hypertens; 2007 Jan; 25(1):169-75. PubMed ID: 17143189
[TBL] [Abstract][Full Text] [Related]
27. Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
Kobrin I; Bieska G; Charlon V; Lindberg E; Pordy R
Cardiology; 1998; 89 Suppl 1():23-32. PubMed ID: 9570426
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the safety and efficacy of mibefradil and nifedipine SR in patients with renal disease and hypertension.
Woittiez AJ; Huysmans FT; Bailey R; Robson RA; Mion Júnior D; Villa G; Kobrin I
Clin Nephrol; 1998 Mar; 49(3):160-6. PubMed ID: 9543597
[TBL] [Abstract][Full Text] [Related]
29. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
[TBL] [Abstract][Full Text] [Related]
30. Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats.
Sharifi AM; Li JS; Endemann D; Schiffrin EL
J Hypertens; 1998 Apr; 16(4):457-66. PubMed ID: 9797191
[TBL] [Abstract][Full Text] [Related]
31. Differential time course of the vasodilator action of various calcium antagonists.
van der Lee R; Kam KL; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 1998; 12(6):607-12. PubMed ID: 9818292
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: comparison with amlodipine.
Roux S; Bühler M; Clozel JP
J Cardiovasc Pharmacol; 1996 Jan; 27(1):132-9. PubMed ID: 8656647
[TBL] [Abstract][Full Text] [Related]
33. Effects of benidipine, a long-lasting dihydropyridine-Ca2+ channel blocker, on cerebral blood flow autoregulation in spontaneously hypertensive rats.
Ikeda J; Yao K; Matsubara M
Biol Pharm Bull; 2006 Nov; 29(11):2222-5. PubMed ID: 17077518
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine.
Véniant M; Clozel JP; Hess P; Wolfgang R
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S55-8. PubMed ID: 1725005
[TBL] [Abstract][Full Text] [Related]
35. Mibefradil, a novel calcium antagonist, in elderly patients with hypertension: favorable hemodynamics and pharmacokinetics.
Bursztyn M; Kadr H; Tilvis R; Martina B; Oigman W; Talberg J; Kobrin I
Am Heart J; 1997 Aug; 134(2 Pt 1):238-47. PubMed ID: 9313603
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular effects of mibefradil in hypertensive patients with obstructive sleep apnea.
Heitmann J; Grote L; Knaack L; Köhler U; Hinder M; Peter JH
Eur J Clin Pharmacol; 1998; 54(9-10):691-6. PubMed ID: 9923569
[TBL] [Abstract][Full Text] [Related]
37. A randomised, double-blind trial comparing mibefradil and amlodipine: two long-acting calcium antagonists with similar efficacy but different tolerability profiles. Mibefradil International Study Group.
Viskoper RJ; Bernink PJ; Schelling A; Ribeiro AB; Kantola IM; Wilkins MR; Kobrin I
J Hum Hypertens; 1997 Jun; 11(6):387-93. PubMed ID: 9249234
[TBL] [Abstract][Full Text] [Related]
38. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
Sandmann S; Claas R; Cleutjens JP; Daemen MJ; Unger T
J Cardiovasc Pharmacol; 2001 Jan; 37(1):64-77. PubMed ID: 11152376
[TBL] [Abstract][Full Text] [Related]
39. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
[TBL] [Abstract][Full Text] [Related]
40. Mibefradil: a new class of calcium-channel antagonists.
Billups SJ; Carter BL
Ann Pharmacother; 1998 Jun; 32(6):659-71. PubMed ID: 9640486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
